Drug intelligence / Profile preview

clobetasol propionate + lactic acid + salicylic acid + urea

Development stage
Unknown
Lead developer
Canixa Life Sciences
Modality
Small Molecules
Administration
Topical
01

Overview

Lozivate MF is a topical combination ointment containing the potent corticosteroid clobetasol propionate, along with the keratolytic and moisturizing agents lactic acid, salicylic acid, and urea. It is primarily indicated for the treatment of severe, dry, and scaly inflammatory skin conditions such as psoriasis, eczema, and dermatitis. Clobetasol propionate acts as an anti-inflammatory agent by binding to glucocorticoid receptors and suppressing the release of inflammatory cytokines. Salicylic acid and lactic acid act as chemical exfoliants (keratolytics) that break down keratin clumps and promote the shedding of dead skin cells, which enhances the penetration of clobetasol. Urea acts as a humectant to draw moisture into the skin, softening thickened plaques and improving skin hydration.

Brand names
Lozivate MF
Other names
clobetasol + lactic acid + salicylic acid + ureaclobetasol propionate, lactic acid, salicylic acid and urea
02

Targets

PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)GR (Glucocorticoid receptor)

Beyond the preview

Go deeper on clobetasol propionate + lactic acid + salicylic acid + urea.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on clobetasol propionate + lactic acid + salicylic acid + urea.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call